Long-Term Patency Rates of Portal Vein/Superior Mesenteric Vein Reconstruction after Pancreatic Resection for Pancreatic Tumors: Single-Center Experience
Abstract
:1. Introduction
2. Methods
2.1. Surgical Technique and Characteristics
2.2. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sgroi, M.D.; Narayan, R.R.; Lane, J.S.; Demirjian, A.; Kabutey, N.K.; Fujitani, R.M.; Imagawa, D.K. Vascular reconstruction plays an important role in the treatment of pancreatic adenocarcinoma. J. Vasc. Surg. 2015, 61, 475–480. [Google Scholar] [CrossRef] [PubMed]
- Bockhorn, M.; Uzunoglu, F.G.; Adham, M.; Imrie, C.; Milicevic, M.; Sandberg, A.A.; Asbun, H.J.; Bassi, C.; Büchler, M.; Charnley, R.M.; et al. Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2014, 155, 977–988. [Google Scholar] [CrossRef] [PubMed]
- Zhou, Y.; Zhang, Z.; Liu, Y.; Li, B.; Xu, D. Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: A meta-analysis. World J. Surg. 2012, 36, 884–891. [Google Scholar] [CrossRef] [PubMed]
- Yu, X.Z.; Li, J.; Fu, D.L.; Di, Y.; Yang, F.; Hao, S.J.; Jin, C. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: A meta-analysis. Eur. J. Surg. Oncol. 2014, 40, 371–378. [Google Scholar] [CrossRef] [PubMed]
- Pindak, D.; Tomas, M.; Dolnik, J.; Duchon, R.; Pavlendova, J. Morbidity, mortality and long term survival in patients with vascular resection in pancreatic cancer—Single center experience. Neoplasma 2017, 64, 460–463. [Google Scholar] [CrossRef]
- Filho, J.E.L.P.; Tustumi, F.; Coelho, F.F.; Júnior, S.S.; Honório, F.C.C.; Henriques, A.C.; Dias, A.R.; Waisberg, J. The impact of venous resection in pancreatoduodectomy: A systematic review and meta-analysis. Medicine 2021, 100, e27438. [Google Scholar] [CrossRef]
- Versteijne, E.; van Dam, J.L.; Suker, M.; Janssen, Q.P.; Groothuis, K.; Akkermans-Vogelaar, J.M.; Besselink, M.G.; Bonsing, B.A.; Buijsen, J.; Busch, O.R.; et al. Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial. J. Clin. Oncol. 2022, 40, 1220–1230. [Google Scholar] [CrossRef]
- Van Dam, J.L.; Janssen, Q.P.; Besselink, M.G.; Homs, M.Y.; van Santvoort, H.C.; van Tienhoven, G.; de Wilde, R.F.; Wilmink, J.W.; van Eijck, C.H.; Koerkamp, B.G. Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials. Eur. J. Cancer 2022, 160, 140–149. [Google Scholar] [CrossRef]
- Conroy, T.; Pfeiffer, P.; Vilgrain, V.; Lamarca, A.; Seufferlein, T.; O’reilly, E.; Hackert, T.; Golan, T.; Prager, G.; Haustermans, K.; et al. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 2023, 34, 987–1002. [Google Scholar] [CrossRef]
- Gemenetzis, G.; Blair, A.B.; Nagai, M.; Groot, V.P.; Ding, D.; Javed, A.A.; Burkhart, R.A.; Fishman, E.K.; Hruban, R.H.; Weiss, M.J.; et al. Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer. Ann. Surg. Oncol. 2022, 29, 401–414. [Google Scholar] [CrossRef]
- Hirono, S.; Kawai, M.; Tani, M.; Okada, K.-I.; Miyazawa, M.; Shimizu, A.; Kitahata, Y.; Yamaue, H. Indication for the use of an interposed graft during portal vein and/or superior mesenteric vein reconstruction in pancreatic resection based on perioperative outcomes. Langenbeck’s Arch. Surg. 2014, 399, 461–471. [Google Scholar] [CrossRef] [PubMed]
- Tseng, J.F.; Raut, C.P.; Lee, J.E.; Pisters, P.W.; Vauthey, J.-N.; Abdalla, E.K.; Gomez, H.F.; Sun, C.C.; Crane, C.H.; Wolff, R.A.; et al. Pancreaticoduodenectomy with vascular resection: Margin status and survival duration. J. Gastrointest. Surg. 2004, 8, 935–950. [Google Scholar] [CrossRef] [PubMed]
- Wolters, U.; Wolf, T.; Stützer, H.; Schröder, T. ASA classification and perioperative variables as predictors of postoperative outcome. Br. J. Anaesth. 1996, 77, 217–222. [Google Scholar] [CrossRef] [PubMed]
- Nakao, A.; Kanzaki, A.; Fujii, T.; Kodera, Y.; Yamada, S.; Sugimoto, H.; Nomoto, S.; Nakamura, S.; Morita, S.; Takeda, S. Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann. Surg. 2012, 255, 103–108. [Google Scholar] [CrossRef] [PubMed]
- DeOliveira, M.L.; Winter, J.M.; Schafer, M.; Cunningham, S.C.; Cameron, J.L.; Yeo, C.J.; Clavien, P.-A. Assessment of Complications after Pancreatic Surgery. Ann. Surg. 2006, 244, 931–939. [Google Scholar] [CrossRef]
- Giovinazzo, F.; Turri, G.; Katz, M.H.; Heaton, N.; Ahmed, I. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma. Br. J. Surg. 2016, 103, 179–191. [Google Scholar] [CrossRef]
- Zwart, E.; Yilmaz, B.; Halimi, A.; Ahola, R.; Kurlinkus, B.; Laukkarinen, J.; Ceyhan, G. Venous resection for pancreatic cancer, a safe and feasible option? A systematic review and meta-analysis. Pancreatology 2022, 22, 803–809. [Google Scholar] [CrossRef]
- Glebova, N.O.; Hicks, C.W.; Piazza, K.M.; Wolfgang, C.L.; Iii, J.H.B. Technical risk factors for portal vein reconstruction thrombosis in pancreatic resection. J. Vasc. Surg. 2014, 62, 424–433. [Google Scholar] [CrossRef]
- Kim, S.M.; Min, S.-K.; Park, D.; Min, S.-I.; Jang, J.-Y.; Kim, S.-W.; Ha, J.; Kim, S.J. Reconstruction of portal vein and superior mesenteric vein after extensive resection for pancreatic cancer. J. Korean Surg. Soc. 2013, 84, 346–352. [Google Scholar] [CrossRef]
- Gao, W.; Dai, X.; Dai, C.; Jiang, K.; Wu, J.; Li, Q.; Guo, F.; Chen, J.; Wei, J.; Lu, Z.; et al. Comparison of patency rates and clinical impact of different reconstruction methods following portal/superior mesenteric vein resection during pancreatectomy. Pancreatology 2016, 16, 1113–1123. [Google Scholar] [CrossRef]
- Chu, C.K.; Farnell, M.B.; Nguyen, J.H.; Stauffer, J.A.; Kooby, D.A.; Sclabas, G.M.; Sarmiento, J.M. Prosthetic Graft Reconstruction after Portal Vein Resection in Pancreaticoduodenectomy: A Multicenter Analysis. J. Am. Coll. Surg. 2010, 211, 316–324. [Google Scholar] [CrossRef] [PubMed]
- Meniconi, R.L.; Santoro, R.; Guglielmo, N.; Vennarecci, G.; Lepiane, P.; Colasanti, M.; Ettorre, G.M. Pancreaticoduodenectomy with venous reconstruction using cold-stored vein allografts: Long-term results of a single center experience. J. Hepato-Biliary-Pancreat. Sci. 2016, 23, 43–49. [Google Scholar] [CrossRef] [PubMed]
- Shao, Y.; Feng, J.; Jiang, Y.; Hu, Z.; Wu, J.; Zhang, M.; Shen, Y.; Zheng, S. Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—Cohort study. BMC Surg. 2021, 21, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Burla, L.; Schwegler, I.; Weibel, P.; Weber, M.; Zientara, A.; Attigah, N. Intraoperatively self-made bovine pericardial graft for portomesenteric reconstruction in pancreatic surgery. Langenbeck’s Arch. Surg. 2020, 405, 705–712. [Google Scholar] [CrossRef] [PubMed]
- Akimaru, K.; Onda, M.; Tajiri, T.; Yoshida, H.; Yokomuro, S.; Mamada, Y.; Taniai, N.; Yoshioka, M.; Mineta, S. Middle hepatic vein reconstruction using a peritoneal patch: Report of a case. Surg. Today 2002, 32, 75–77. [Google Scholar] [CrossRef]
- Dokmak, S. Pancreaticoduodenectomy with Reconstruction of the Mesentericoportal Vein by the Parietal Peritoneum: ‘Safi Dokmak Vascular Graft’. Ann. Surg. Oncol. 2015, 22, 343–344. [Google Scholar] [CrossRef]
- Lapergola, A.; Felli, E.; Rebiere, T.; Mutter, D.; Pessaux, P. Autologous peritoneal graft for venous vascular reconstruction after tumor resection in abdominal surgery: A systematic review. Updat. Surg. 2020, 72, 605–615. [Google Scholar] [CrossRef]
- Fujii, T.; Nakao, A.; Yamada, S.; Suenaga, M.; Hattori, M.; Takami, H.; Inokawa, Y.; Kanda, M.; Sugimoto, H.; Nomoto, S.; et al. Vein resections >3 cm during pancreatectomy are associated with poor 1-year patency rates. Surgery 2015, 157, 708–715. [Google Scholar] [CrossRef]
- Mohammed, S.; Mendez-Reyes, J.E.; McElhany, A.; Gonzales-Luna, D.; Van Buren, G.; Bland, D.S.; Villafane-Ferriol, N.; Pierzynski, J.A.; West, C.A.; Silberfein, E.J.; et al. Venous thrombosis following pancreaticoduodenectomy with venous resection. J. Surg. Res. 2018, 228, 271–280. [Google Scholar] [CrossRef]
- Stauffer, J.A.; Dougherty, M.K.; Kim, G.P.; Nguyen, J.H. Interposition graft with polytetrafluoroethylene for mesenteric and portal vein reconstruction after pancreaticoduodenectomy. Br. J. Surg. 2009, 96, 247–252. [Google Scholar] [CrossRef]
- Smoot, R.L.; Christein, J.D.; Farnell, M.B. Durability of Portal Venous Reconstruction Following Resection during Pancreaticoduodenectomy. J. Gastrointest. Surg. 2006, 10, 1371–1375. [Google Scholar] [CrossRef] [PubMed]
- Song, W.; Yang, Q.; Chen, L.; Sun, Q.; Zhou, D.; Ye, S.; Hu, Z.; Wu, L.; Feng, L.; Zheng, S. Pancreatoduodenectomy combined with portal-superior mesenteric vein resection and reconstruction with interposition grafts for cancer: A meta-analysis. Oncotarget 2017, 8, 81520–81528. [Google Scholar] [CrossRef] [PubMed]
- Ravikumar, R.; Sabin, C.; Abu Hilal, M.; Al-Hilli, A.; Aroori, S.; Bond-Smith, G.; Bramhall, S.; Coldham, C.; Hammond, J.; Hutchins, R.; et al. Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic cancer. Br. J. Surg. 2017, 104, 1539–1548. [Google Scholar] [CrossRef] [PubMed]
- Kang, M.J.; Jang, J.-Y.; Chang, Y.R.; Jung, W.; Kim, S.-W. Portal vein patency after pancreatoduodenectomy for periampullary cancer. Br. J. Surg. 2015, 102, 77–84. [Google Scholar] [CrossRef]
- Labori, K.J.; Kleive, D.; Khan, A.; Farnes, I.; Fosby, B.; Line, P.-D. Graft type for superior mesenteric and portal vein reconstruction in pancreatic surgery—A systematic review. HPB 2021, 23, 483–494. [Google Scholar] [CrossRef]
Type | Classification |
---|---|
I | Partial venous excision with direct closure by suture closure (venorraphy) |
II | Partial venous excision using a patch (venoplasty) |
III | Segmential resection with primary veno-venous anastomosis end-to-end |
IV | Segmental resection with interposed venous conduit (graft) and at least two anastomoses |
Cohort 1 Patency after 1 Year | Cohort 2 Occlusion/Stenosis after 1 Year | p Value | |
---|---|---|---|
Number (n/%) | 37/90.2 | 4/9.8 | |
Gender (male/female %) | 54.1/45.9 | 50.0/50.0 | >0.9999 1 |
ASA classification grade 1/2/3/4 (n) | 2/23/12/0 | 0/4/0/0 | 0.3056 1 |
Nakao classification grade B/C/D (%) | 59.5/29.7/10.8 | 0/100.0/0 | 0.5166 1 |
Total Pancreatectomy/Pancreatoduodenectomy/Distal Pancreatosplenectomy (n/%) | 25 (67.6)/11 (29.7)/ 1 (2.7) | 2 (50.0)/2 (50.0)/0 | 0.5956 1 |
Cohort 1 Patency after 1 Year | Cohort 2 Occlusion/Stenosis after 1 Year | p Value | |
---|---|---|---|
Type of operation n (%) | 0.5956 1 | ||
PD | 11 (29.7) | 2 (50.0) | |
TP | 25 (67.6) | 2 (50.0) | |
DP | 1 (2.7) | 0 | |
Surgery duration (min, mean ± SD) | 395.5 ± 78.1 | 416 ± 179.3 | 0.6941 1 |
Blood loss (mL, mean ± SD) | 421.9 ± 260.1 | 312.5 ± 131.5 | 0.6345 1 |
Type of resected vein | 0.710 2 | ||
PV | 16 (43.3) | 1 (25.0) | |
SMV | 11 (29.7) | 2 (50.0) | |
PV-SMC confluence | 10 (27.0) | 1 (25.0) | |
Type of reconstruction n (%) | 0.3433 3 | ||
Interposition graft (PTFE) | 17 (45.9) | 3 (75.0) | |
No interposition graft | 20 (54.1) | 1 (25.0) | |
Vascular clamp time (min, mean ± SD) | 22.3 ± 9.96 | 30.0 ± 12.9 | 0.2434 1 |
Multivisceral resection | 6 (16.2) | 0 | >0.9999 3 |
Perioperative complications | |||
POPF | >0.9999 3 | ||
Grade A | 3 | 0 | |
Grade B | 0 | 0 | |
Grade C | 0 | 0 | |
PPH | 0.0952 1 | ||
Grade A | 1 | 1 | |
Grade B | 2 | 1 | |
Grade C | 5 | 0 | |
Postoperative infectious complications | |||
Intra-abdominal abscess | 2 | 0 | >0.9999 1 |
SIRS/sepsis | 13 | 1 | >0.9999 3 |
Surgical reoperation n (%) | 6 (12.5) | 1 (20.0) | 0.3478 1 |
30-day mortality n (%) | 2 (5.4) | 0 | 0.99 3 |
Clavien–Dindo | Cohort 1 Patency after 1 Year n = 37 (n/%) | Cohort 2 Occlusion/Stenosis after 1 Year n = 4 (n/%) | p Value |
---|---|---|---|
1 | 13/35.1 | 2/50.0 | |
2 | 16/51.4 | 0 | |
3a | 2/5.4 | 1/25.0 | |
3b | 3/8.1 | 1/25.0 | |
4a | 3 | 0 | 0.0846 1 |
4b | 0 | 0 | |
5 | 0 | 0 |
Time Point | Baseline | 3 mo | 6 mo | 9 mo | 12 mo |
---|---|---|---|---|---|
Rate of thrombosis (%) | 0% | 2% | 4.1% | 4.5% | 9.8% |
Rate of patency (%) | 100% | 98% | 95.9% | 95.9% | 90.2% |
Total patients with thrombosis (n) | 0 | 1 | 2 | 2 | 5 |
Total alive patients with thrombosis (n) | 0 | 1 | 2 | 1 | 4 |
Total alive patients PD + VR (n) | 53 | 50 | 49 | 44 | 41 |
Percentage of original patients still alive (%) | 100% | 94.3% | 92.5% | 83% | 77.4% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tomas, M.; Dubovan, P.; Pavlendova, J.; Aziri, R.; Jurik, M.; Duchon, R.; Bernadic, M.; Novotna, N.; Dolnik, J.; Pindak, D. Long-Term Patency Rates of Portal Vein/Superior Mesenteric Vein Reconstruction after Pancreatic Resection for Pancreatic Tumors: Single-Center Experience. Life 2024, 14, 1175. https://doi.org/10.3390/life14091175
Tomas M, Dubovan P, Pavlendova J, Aziri R, Jurik M, Duchon R, Bernadic M, Novotna N, Dolnik J, Pindak D. Long-Term Patency Rates of Portal Vein/Superior Mesenteric Vein Reconstruction after Pancreatic Resection for Pancreatic Tumors: Single-Center Experience. Life. 2024; 14(9):1175. https://doi.org/10.3390/life14091175
Chicago/Turabian StyleTomas, Miroslav, Peter Dubovan, Jana Pavlendova, Ramadan Aziri, Miroslav Jurik, Robert Duchon, Michal Bernadic, Nina Novotna, Jozef Dolnik, and Daniel Pindak. 2024. "Long-Term Patency Rates of Portal Vein/Superior Mesenteric Vein Reconstruction after Pancreatic Resection for Pancreatic Tumors: Single-Center Experience" Life 14, no. 9: 1175. https://doi.org/10.3390/life14091175